Inactive Instrument

Calendar Purple Biotech Ltd. TEL AVIV STOCK EXCHANGE

Equities

PPBT

IL0007650166

Chart calendar Purple Biotech Ltd.

20447b0.JrIozHsG4UZHAEkWmFwvMhcoAQ8QqPV65xmBpYH322I.XtRb9B5X0w0xTD990wtsXWAbajhfxLEyiSjm07mdvjtqh3KvCT7RECRZBA~e0ff83e86a5e5742f2a299b63081ea87

Upcoming events on Purple Biotech Ltd.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number: LBA4143
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-02-04 Q4 2024 Earnings Release (Projected)

Past events on Purple Biotech Ltd.

2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract Number 5181
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract Number 1939
2024-03-05 07:55 am Q4 2023 Earnings Release
2023-11-21 06:50 am Q3 2023 Earnings Release
2023-09-28 04:40 pm American Association for Cancer Research Special Conference
2023-08-22 09:29 am Q2 2023 Earnings Release
2023-05-16 04:00 pm Q1 2023 Earnings Release
2023-04-20 02:00 pm Canaccord Genuity Horizons in Oncology Virtual Conference - Panel
2021-06-04 08:30 am Jefferies Healthcare Conference
2021-06-03 American Society of Clinical Oncology Conference
2021-04-10 01:30 am American Association for Cancer Research Conference
2021-03-02 07:00 am FY 2020 Earnings Release
2021-01-20 10:30 am B. Riley Oncology Investor Conference
2021-01-05 LifeSci Advisors Corporate Access Event
2020-11-16 Jefferies Healthcare Conference
2020-11-12 09:00 am H.C. Wainwright Israel Conference
2020-08-11 07:15 am Interim 2020 Earnings Release
2020-06-21 American Association for Cancer Research Virtual Meeting
2020-05-29 08:00 am American Society of Clinical Oncology Virtual Annual Meeting - Abstract No 3094
2020-02-26 Multidisciplinary Head and Neck Cancers Symposium - Presentation Number : 312

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


1,00
4,70
-78.72%
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,6
-5,81
-117.15%
0,00


-22,6
-21,7
-4.16%
-22,3
-20,4
-9.17%

-18,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-17,8


0,00
0,00
-
0,00
0,00
-

0,00

Net income
Million USD
Released
Forecast
Spread
-5,85


-28,0
0,00
-
-18,4


0,00
0,00
-
0,00
0,00
-

0,00

EPS
USD
Released
Forecast
Spread
-0,30


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date11/02/2002/03/2109/02/2208/02/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread



-5,08
-4,00
-27.03%
-6,60
-5,70
-15.81%
-5,12
-6,90
25.77%
-5,14
-5,00
-2.7%
-5,75
-4,70
-22.28%
-6,27
-4,40
-42.43%

-5,20


-4,70


-4,30


-3,90

Net income
Million USD
Released
Forecast
Spread
-10,8
































EPS
USD
Released
Forecast
Spread
-0,06
































Announcement Date04/08/2208/11/2208/02/2316/05/2322/08/2321/11/2305/03/24----
  1. Stock Market
  2. Equities
  3. PPBT Stock
  4. PPBT Stock
  5. Calendar Purple Biotech Ltd.